Accelerate Diagnostics, Inc·4

Mar 9, 4:24 PM ET

MILLER MARK C 4

4 · Accelerate Diagnostics, Inc · Filed Mar 9, 2023

Insider Transaction Report

Form 4
Period: 2023-03-07
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-07+4,39655,282 total
  • Exercise/Conversion

    Employee Restricted Stock Units

    2023-03-0750,8860 total
    Common Stock (50,886 underlying)
  • Exercise/Conversion

    Employee Restricted Stock Units

    2023-03-074,3960 total
    Common Stock (4,396 underlying)
  • Exercise/Conversion

    Common Stock

    2023-03-07+50,88650,886 total
Holdings
  • Common Stock

    (indirect: By Trust)
    39,062
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. This reporting person received a prorated amount of 50,886 RSUs, which is eight of the twelve months.
  • [F2]The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 4,396 RSUs. All of the RSUs vested on the first-year anniversary of the Date of Grant. These RSUs are subject to the Company's Director Equity Deferral Program and were released within 30 days of separation from service.

Documents

1 file
  • 4
    wf-form4_167839708247437.xmlPrimary

    FORM 4